Diabetes is a very prevalent disease that, unfortunately, still has no treatment. People with diabetes need to monitor their blood glucose levels (BGLs) regularly and administer insulin to keep them in check. In almost all cases, BGL measurements involve drawing blood from a fingertip through a finger prick. Since this procedure is painful, less invasive alternatives that leverage modern electronics are being actively researched worldwide.
CEO Doug Drysdale Explains Cybin Patent Approvals
The Dales Report is back with another Psychedelic Exclusive. Today we welcome Cybin CEO Doug Drysdale to the mic. Cybin is a clinical-stage biopharmaceutical company